Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination

Abstract Background Eliminating hepatitis C virus (HCV) infections is a goal set by the World Health Organization. This has become possible with the introduction of highly effective and safe direct-acting antivirals (DAA) but limitations remain due to undiagnosed HCV infections and loss of patients...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-10-01
Series:	BMC Medicine
Assuntos:	HCV Lost to follow-up Treatment Direct-acting antivirals
Acceso en liña:	https://doi.org/10.1186/s12916-024-03699-z
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!